This website uses cookies

This websites contains videos from YouTube. This company uses cookies (third party cookies). If you do not want them to use these cookies, you can indicate so here. However, this does mean that you will not be able to watch videos on this website. We also make use of our own cookies in order to improve our website. We don't share our data with other parties. Which cookies are involved?

This website uses cookies to enable video and to improve the user experience. If you do not want to accept these cookies, indicate so here. Which cookies are involved?

Ga direct naar de inhoud, het hoofdmenu, het servicemenu of het zoekveld.


20Mar 2020

Back to Seminars overview

International seminar by Christopher Sweeney

Christopher Sweeney
Dana Farber Cancer Institute, Boston, USA

The way forward in prostate cancer is by going backwards

Friday, March 20, 2020, 11:00 hours
Piet Borst Auditorium, Netherlands Cancer Institute, Amsterdam

Christopher Sweeney
Dr. Christopher J. Sweeney is a medical oncologist at Dana-Farber Cancer Institute and Professor of Medicine at Harvard Medical School. In 1992, Dr. Sweeney received his medical degree from the University of Adelaide in Australia and completed his residency in internal medicine at Gundersen Lutheran Medical Center, Wisconsin and a fellowship in hematology/oncology at Indiana University Medical Center, where he was later appointed Associate Director for Clinical Research for the Simon Cancer Center. In 2009, he joined the Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute and Harvard Medical School. Dr. Sweeney is a member of the American Society of Clinical Oncology, the Eastern Cooperative Oncology Group-ACRIN, Alliance and the American Association for Cancer Research. His primary research interest is biomarker drug discovery and development and development of surrogacy endpoints. His academic focus is the management of genitourinary malignancies, particularly prostate and testicular cancer.


Share this page